CN102603620A - Synthetic method of chloromethylpyridine or pyridine derivative hydrochloride of chloromethylpyridine - Google Patents

Synthetic method of chloromethylpyridine or pyridine derivative hydrochloride of chloromethylpyridine Download PDF

Info

Publication number
CN102603620A
CN102603620A CN2012100109700A CN201210010970A CN102603620A CN 102603620 A CN102603620 A CN 102603620A CN 2012100109700 A CN2012100109700 A CN 2012100109700A CN 201210010970 A CN201210010970 A CN 201210010970A CN 102603620 A CN102603620 A CN 102603620A
Authority
CN
China
Prior art keywords
pyridine
reaction
compound method
pyridine derivate
chlorination
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN2012100109700A
Other languages
Chinese (zh)
Other versions
CN102603620B (en
Inventor
秦必政
薛谊
徐强
李维思
赵华阳
周颖
钱勇
肖云
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Jiangsu Zhongbang Pharmaceutical Coltd
Original Assignee
Jiangsu Zhongbang Pharmaceutical Coltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jiangsu Zhongbang Pharmaceutical Coltd filed Critical Jiangsu Zhongbang Pharmaceutical Coltd
Priority to CN201210010970.0A priority Critical patent/CN102603620B/en
Publication of CN102603620A publication Critical patent/CN102603620A/en
Application granted granted Critical
Publication of CN102603620B publication Critical patent/CN102603620B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Pyridine Compounds (AREA)

Abstract

The invention discloses a synthetic method of chloromethylpyridine or pyridine derivative hydrochloride of the chloromethylpyridine. The synthetic method is characterized in that according to the method, the positioning effect of substitutional groups is used for carrying out chloromethylation reaction, raw materials of pyridine or pyridine derivatives are subjected to Friedel-Crafts acylation reaction under the catalyst effect, No.2 sites or No.6 sites of the pyridine or the pyridine derivatives take electrophilic substitution reaction, then, hydroxymethylpyridine or hydroxymethylpyridine derivatives are obtained through reduction reaction, next, the chloromethylpyridine or the pyridine derivative hydrochloride is obtained through chlorination reaction, and the structure of the obtained product is shown as the accompanying drawing. The method has the advantages that the reaction steps are few, the cost is low, the purity is high, the yield is high, the operation is safe, and the method is suitable for large-scale industrial production.

Description

The compound method of a kind of PMC or its pyridine derivate hydrochloride
Technical field:
The invention belongs to chemical field; Be specifically related to the compound method of a kind of PMC or its pyridine derivate hydrochloride; PMC and pyridine derivate hydrochloride are the important industrial chemicals of various agricultural chemicals, medicine intermediate, Insecticides (tech) & Herbicides (tech), sterilant, and present method directly generates 2-PMC and pyridine derivate from pyridine or its pyridine derivate.
Background technology:
PMC and pyridine derivate hydrochloride are the important industrial chemicals of various agricultural chemicals, medicine intermediate, Insecticides (tech) & Herbicides (tech), sterilant.Pyridine and pyridine derivate are directly gone up methyl at present, and with expensive precious metal industrial chemicals such as lithium methide, methyl iodide, perhaps just direct cyclization becomes methyl is arranged on the 2-position, leads to chlorine again, carries out chlorination.The technology that has is on oxygen, to methylate for pyridine nitric oxide with methyl-sulfate; And then carry out making 2-4-hydroxymethylpiperidine and pyridine derivate after the oxidation; Chlorination gets 2-PMC and pyridine derivate hydrochloride again, as: US4620008, CN101337924A, SE0103553 etc.Pyridine and pyridine derivate carry out connecing synthetic industrial chemicals midbody and the bulk drug that high added value is arranged of other groups more easily behind the chloromethylation.But use lithium methide, methyl iodide etc. to be raw material, cost value pressure is big, and it is cumbersome to reclaim precious metal and iodine element; Big with methyl-sulfate toxicity, for the operation hazardous that feeds intake.
Summary of the invention
The compound method that the purpose of this invention is to provide a kind of PMC and pyridine derivate hydrochloride.
The objective of the invention is through following scheme implementation:
The compound method of a kind of PMC or pyridine derivate hydrochloride, this method be with pyridine or pyridine derivate through peroxo-, catalysis ethanoylization, restore with chlorination and obtain PMC or pyridine derivate hydrochloride.
The present invention is through following scheme implementation:
The compound method of a kind of PMC or its pyridine derivate hydrochloride; It is characterized in that this method uses substituent orientation effect to carry out chloromethylation; This method comprises carries out friedel-crafts acylation reaction with pyridine or pyridine derivate and acylting agent under catalyst action; Electrophilic substitution reaction takes place in No. 2 positions or No. 6 positions at pyridine or pyridine derivate; Obtain 4-hydroxymethylpiperidine or 4-hydroxymethylpiperidine verivate through reduction then, obtain PMC or pyridine derivate hydrochloride through chlorination again.The product structure that obtains is following:
Described pyridine derivate is preferably nitrogen pyridine oxide verivate, wherein, and preferred R 1Be H, CH 3, CH 2CH 3, Cl, OCH 3, NH 2Or NO 2Preferred R 2Be H, CH 3, CH 2CH 3, Cl, OCH 3, NH 2Or NO 2Preferred R 3Be H, CH 3, CH 2CH 3, Cl, OCH 3, NH 2Or NO 2Has only H on No. 2 positions of the pyridine ring of described raw material pyridine and pyridine derivate, No. 6 positions.
The temperature of reaction of described acylation reaction is 45 ℃~95 ℃, the reaction times be 4~16h (preferred 4~6h), raw material pyridine or pyridine derivate: acylting agent: catalyzer=1: 1~2.5: 0.1~0.5 (mol ratio); The temperature of reaction of described reduction reaction is 45 ℃~95 ℃, and the reaction times is 5~16h (preferred 5~12h, most preferably 5~7h); Chlorination temperature is in the described chlorination :-20 ℃~-5 ℃, the reaction times is 1~3h.
The used acylting agent of described friedel-crafts acylation reaction is carboxylic acid halides or acid anhydrides.Preferred acylting agent is: RCOI, RCOBr, RCOCl, RCOF, (RCO) O; Described R is preferably CH 3, CH 3CH 2, CH 2=CH or CH 3(CH 2) n, 3>=n>=1 wherein.
The catalyzer that friedel-crafts acylation reaction of the present invention adopts is Lewis acid; The preferred AlCl of described Lewis acid 3, ZnCl 2, MgO, ZnO, K 2CO 3Or Na 2CO 3
The preferred Fe/AcOH of reductive agent, Na/EtOH, Zn/NaOH, zinc amalgam, Peng Qinghuana, Lithium Aluminium Hydride, tetrahydro boron sodium, Raney nickel or palladium charcoal that reduction step of the present invention adopts; The reductive agent consumption is the mass ratio 1 with raw material pyridine or pyridine derivate: 0.5-2; The preferred SOCl of reagent that described chlorination adopts 2, POCl 3, PCl 3, Cl 2Or HCl.The consumption of chlorination reagent for raw material pyridine or pyridine derivate mass ratio be 1: 0.5-4.
With the raw material is that pyridine is that example is reacted as follows:
Figure BDA0000130897890000022
Wherein, R 1, R 2And R 3Be H.
With prior art beneficial effect more of the present invention: the present invention adopts the industrial chemicals that contains pyridine ring commonly used to carry out the acetyl glycosylation reaction, and reactions step is few, and cost is low, and purity is high, and yield is high, and operational safety, the inventive method are suitable for large-scale industrial production.
Embodiment:
Further understand the present invention through following examples, but can not limit content of the present invention.
Embodiment 1
The 4-methoxyl group-3 that in the flask of 500ml, adds 9.2g, 5-lutidine oxynitride, the methyl alcohol of 60ml; Add the 0.8g aluminum chloride, be cooled to and begin to drip Vinyl chloroformate 7.8g below 0 ℃, after dropwising; Being warming up to temperature of reaction is 45 ℃~95 ℃, back flow reaction 4~6 hours, sampling analysis; Until raw material 4-methoxyl group-3, till 5-lutidine oxynitride does not reduce; In system, add the 6.75g tetrahydro boron sodium, temperature of reaction is 55-65 ℃, reduces.Reacted 5 hours, and filtered, filter out inorganic salt, filtrating steaming is removed methyl alcohol; Go out 2-methylol-4-methoxyl group-3,5-lutidine, dry methylene chloride phase with dichloromethane extraction; Be cooled to-10 ℃ and begin to drip the 14g sulfur oxychloride, and then be warming up to room temperature reaction naturally 2~3 hours, get 2-chloromethyl-4-methoxyl group-3; 5-dimethyl pyrazole thiamine hydrochloride, weigh the 10.8g white solid, analyze through HPLC: purity is 98.37%.The three-step reaction total recovery is 81.2%.
Embodiment 2
The 4-nitro-3 that in the flask of 500ml, adds 10g, 5-lutidine oxynitride, the methyl alcohol of 60ml; Add 0.5g Natural manganese dioxide, be cooled to and begin to drip diacetyl oxide 6.2g below 0 ℃, after dropwising; Being warming up to temperature of reaction is 45 ℃~95 ℃, back flow reaction 4~6 hours, sampling analysis; Until raw material 4-nitro-3, till 5-lutidine oxynitride does not reduce; In system, add the 6.75g Lithium Aluminium Hydride, temperature of reaction is 85-95 ℃, reduces.Reacted 7 hours, and filtered, leach inorganic salt, filtrating steaming is removed methyl alcohol; Go out 2-methylol-4-nitro-3,5-lutidine, dry methylene chloride phase with dichloromethane extraction; Be cooled to-20 ℃ and begin to drip the 18g phosphorus trichloride, and then be warming up to room temperature reaction naturally 2~3 hours, get 2-chloromethyl-4-nitro-3; 5-dimethyl pyrazole thiamine hydrochloride, weigh 11.9g off-white color solid, analyze through HPLC: purity is 97.73%.The three-step reaction total recovery is 84.4%.
Embodiment 3
In the flask of 500ml, add 3 of 7.3g, 5-lutidine oxynitride, the methyl alcohol of 60ml adds the 4.0g zinc chloride, is cooled to begin to drip chloracetyl (CH below 0 ℃ 3COCl) 9.3g, after dropwising, being warming up to temperature of reaction is 45 ℃~95 ℃, back flow reaction 4~6 hours, sampling analysis is until raw material 3, till 5-lutidine oxynitride does not reduce; In system, add 6.75gFe/10mlAcOH, temperature of reaction is 45-55 ℃, reduces.Reacted 12 hours, and filtered out inorganic salt, steam and remove methyl alcohol; Go out 2-methylol-3 with dichloromethane extraction, 5-lutidine, dry methylene chloride phase; Be cooled to-5 ℃ and begin to feed 8.4g chlorine, and then be warming up to room temperature reaction naturally 1~2 hour, get 2-chloromethyl-3; 5-dimethyl pyrazole thiamine hydrochloride, weigh the 9.1g white solid, analyze through HPLC: purity is 98.45%.The three-step reaction total recovery is 80.5%.
Embodiment 4
The pyridine nitric oxide that in the flask of 500ml, adds 5.6g, the methyl alcohol of 60ml adds 1.6g salt of wormwood; Be cooled to and begin to drip propionic anhydride 19.2g below 0 ℃, after dropwising, being warming up to temperature of reaction is 45 ℃~95 ℃; Back flow reaction 4~6 hours; Sampling analysis is until raw material 3, till 5-lutidine oxynitride does not reduce; In system, add 10gRaney nickel, reduce, temperature of reaction is 55-65 ℃, reacts 5 hours; Filter out inorganic salt, steam and remove methyl alcohol, go out 2-methylol-3 with dichloromethane extraction, the 5-lutidine; The dry methylene chloride phase is cooled to-15 ℃ and feeds 4.3g hydrogenchloride, and then was warming up to room temperature reaction naturally 2~3 hours; The 2-chloromethyl pyridine hydrochloride, weigh the 8.9g colorless solid, analyze through HPLC: purity is 95.83%.The three-step reaction total recovery is 88.7%.
Embodiment 5
The pyridine that in the flask of 500ml, adds 4g, the methyl alcohol of 60ml adds the 2.0g aluminum chloride; Be cooled to and begin to drip Vinyl chloroformate 12.6g below 0 ℃, after dropwising, being warming up to temperature of reaction is 45 ℃~95 ℃; Back flow reaction 4~6 hours; Sampling analysis is until raw material 4-methoxyl group-3, till 5-lutidine oxynitride does not reduce; In system, add the 6.75g tetrahydro boron sodium, reduce.Temperature of reaction is 55-65 ℃, reacts 5 hours, filters; Filter out inorganic salt, filtrating steaming is removed methyl alcohol, goes out the 2-4-hydroxymethylpiperidine with dichloromethane extraction; The dry methylene chloride phase is cooled to-10 ℃ and begins to drip the 14g sulfur oxychloride, and then was warming up to room temperature reaction naturally 2~3 hours; The 2-chloromethyl pyridine hydrochloride, weigh the 6.8g white solid, analyze through HPLC: purity is 99.3%.The three-step reaction total recovery is 81.9%.
Embodiment 6
The 4-amino-3 that in the flask of 500ml, adds 8.2g, 5-lutidine oxynitride, the methyl alcohol of 60ml; Add 0.84g Natural manganese dioxide, be cooled to and begin to drip diacetyl oxide 9.7g below 0 ℃, after dropwising; Being warming up to temperature of reaction is 45 ℃~95 ℃, back flow reaction 4~6 hours, sampling analysis; Until raw material 4-amino-3, till 5-lutidine oxynitride does not reduce; In system, add the 6.75g Lithium Aluminium Hydride, reduce.Temperature of reaction is 85-95 ℃, reacts 5 hours, filters, and leaches inorganic salt; Filtrating steaming is removed methyl alcohol, goes out 2-methylol-4-amino-3,5-lutidine, dry methylene chloride phase with dichloromethane extraction; Be cooled to-10 ℃ and begin to drip the 18g phosphorus trichloride, and then be warming up to room temperature reaction naturally 2~3 hours, get 2-chloromethyl-4-amino-3; 5-dimethyl pyrazole thiamine hydrochloride, weigh 10.5g off-white color solid, analyze through HPLC: purity is 97.73%.The three-step reaction total recovery is 85.4%.
Embodiment 7
The 4-chloro-3 that in the flask of 500ml, adds 9.3g, 5-lutidine oxynitride, the methyl alcohol of 60ml adds the 3.2g zinc chloride, is cooled to begin to drip chloracetyl (CH below 0 ℃ 3COCl) 10.65g, after dropwising, being warming up to temperature of reaction is 45 ℃~95 ℃, back flow reaction 9~10 hours, sampling analysis is until raw material 4-chlorine 3, till 5-lutidine oxynitride does not reduce; In system, add 6.75gFe/10mlAcOH, reduce.Temperature of reaction is 55-65 ℃, reacts 5 hours, filters out inorganic salt, steams and removes methyl alcohol; Go out 2-methylol-4-chloro-3,5-lutidine, dry methylene chloride phase with dichloromethane extraction; Be cooled to subzero 10 ℃ and begin to feed 8.4g chlorine, and then be warming up to room temperature reaction naturally 2~3 hours, get 2-chloromethyl-4-chloro-3; 5-dimethyl pyrazole thiamine hydrochloride, weigh the 11.1g white solid, analyze through HPLC: purity is 98.65%.The three-step reaction total recovery is 82.8%.
Embodiment 8
The 3-ethylpyridine oxynitride that in the flask of 500ml, adds 7.3g, the methyl alcohol of 60ml adds 1.6g salt of wormwood; Be cooled to and begin to drip propionic anhydride 19.3g below 0 ℃; After dropwising, being warming up to temperature of reaction is 45 ℃~95 ℃, back flow reaction 4~6 hours; Sampling analysis is not till raw material 3-ethylpyridine oxynitride reduces; In system, add 10gRaney nickel, reduce.Temperature of reaction is 75-85 ℃, reacts 5 hours, filters out inorganic salt; Steam and remove methyl alcohol, go out 2-methylol-3 with dichloromethane extraction, the 5-lutidine; The dry methylene chloride phase is cooled to subzero 10 ℃ and feeds 4.3g hydrogenchloride, and then was warming up to room temperature reaction naturally 2~3 hours; 2-chloromethyl 3-ethylpyridine hydrochloride, weigh the 9.6g colorless solid, analyze through HPLC: purity is 95.83%.The three-step reaction total recovery is 85%.

Claims (10)

1. the compound method of a PMC or its pyridine derivate hydrochloride is characterized in that this method may further comprise the steps:
Raw material pyridine or pyridine derivate and acylting agent are carried out friedel-crafts acylation reaction under catalyst action; Electrophilic substitution reaction takes place in No. 2 positions or No. 6 positions at pyridine or pyridine derivate; Obtain 4-hydroxymethylpiperidine or 4-hydroxymethylpiperidine verivate through reduction reaction then; Obtain PMC or pyridine derivate hydrochloride through chlorination again, the product structure that obtains is following:
Figure FDA0000130897880000011
2. compound method according to claim 1; The temperature of reaction that it is characterized in that described friedel-crafts acylation reaction is 45 ℃~95 ℃; Reaction times is 4~16h, wherein, and raw material pyridine or pyridine derivate: acylting agent: catalyzer=1: 1~2.5: 0.1~0.5; The temperature of reaction of described reduction reaction is 45 ℃~95 ℃, and the reaction times is 5~16h; Chlorination temperature is in the described chlorination :-20 ℃~-5 ℃, the reaction times is 1~3h.
3. compound method according to claim 1 is characterized in that described pyridine derivate is a nitrogen pyridine oxide verivate.
4. compound method according to claim 1 is characterized in that described R 1Be H, CH 3, CH 2CH 3, Cl, OCH 3, NH 2Or NO 2R 2Be H, CH 3, CH 2CH 3, Cl, OCH 3, NH 2Or NO 2R 3Be H, CH 3, CH 2CH 3, Cl, OCH 3, NH 2Or NO 2
5. compound method according to claim 1 and 2 is characterized in that the used acylting agent of described friedel-crafts acylation reaction is carboxylic acid halides or acid anhydrides.
6. compound method according to claim 5 is characterized in that described acylting agent is: RCOI, RCOBr, RCOCl, RCOF, (RCO) O; Described R is CH 3, CH 3CH 2, CH 2=CH or CH 3(CH 2) n, 3>=n>=1 wherein.
7. compound method according to claim 1 and 2 is characterized in that the catalyzer that described friedel-crafts acylation reaction adopts is Lewis acid.
8. compound method according to claim 7 is characterized in that described Lewis acid is AlCl 3, ZnCl 2, MgO, ZnO, K 2CO 3Or Na 2CO 3
9. compound method according to claim 1 and 2 is characterized in that the reductive agent that described reduction reaction adopts is: Fe/AcOH, Na/EtOH, Zn/NaOH, zinc amalgam, Peng Qinghuana, Lithium Aluminium Hydride, tetrahydro boron sodium, Raney nickel or palladium charcoal; The reductive agent consumption is 1 for the mass ratio with raw material pyridine or pyridine derivate: 0.5-2.
10. compound method according to claim 1 and 2 is characterized in that the reagent that described chlorination adopts is SOCl 2, POCl 3, Cl 2, PCl 3, or HCl; The consumption of chlorination reagent for raw material pyridine or pyridine derivate mass ratio be 1: 0.5-4.
CN201210010970.0A 2012-01-13 2012-01-13 Synthetic method of chloromethylpyridine or pyridine derivative hydrochloride of chloromethylpyridine Active CN102603620B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201210010970.0A CN102603620B (en) 2012-01-13 2012-01-13 Synthetic method of chloromethylpyridine or pyridine derivative hydrochloride of chloromethylpyridine

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201210010970.0A CN102603620B (en) 2012-01-13 2012-01-13 Synthetic method of chloromethylpyridine or pyridine derivative hydrochloride of chloromethylpyridine

Publications (2)

Publication Number Publication Date
CN102603620A true CN102603620A (en) 2012-07-25
CN102603620B CN102603620B (en) 2014-10-29

Family

ID=46521461

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201210010970.0A Active CN102603620B (en) 2012-01-13 2012-01-13 Synthetic method of chloromethylpyridine or pyridine derivative hydrochloride of chloromethylpyridine

Country Status (1)

Country Link
CN (1) CN102603620B (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103880741A (en) * 2014-02-28 2014-06-25 安徽国星生物化学有限公司 Preparation method of 2-chloromethyl-3,5-dimethyl-4-alkoxypyridyl-N-oxide
CN104974078A (en) * 2015-06-25 2015-10-14 黄荣辉 Preparation method of 2-methyl-6-chloromethylpyridinehydrochloride
CN105198799A (en) * 2015-11-03 2015-12-30 江苏梦得电镀化学品有限公司 Preparation method of 2-methyl-6-(chloromethyl) pyridine hydrochloride
CN111638303A (en) * 2020-06-08 2020-09-08 安徽大学 Distinguish metal ion Al3+And Zn2+Method (2)

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4620008A (en) * 1982-08-26 1986-10-28 Aktiebolaget Hassle Processes for the preparation of omeprazole and intermediates therefore
CN1042705A (en) * 1988-11-15 1990-06-06 Cl药物股份公司 3,5-dimethyl-4-methoxypyridine derivatization method and be used for the novel intermediate product of this method for making
CN1098405A (en) * 1993-07-02 1995-02-08 拜尔公司 The method for preparing chloromethyl pyridine compound
CN1135481A (en) * 1994-12-23 1996-11-13 拜尔公司 Preparation method for chloromethyl pyridine compound
US6245913B1 (en) * 1999-06-30 2001-06-12 Wockhardt Europe Limited Synthetic procedure for 5-methoxy-2-[(4-methoxy-3,5-dimethyl-2-pyridinyl)-methylthio]-IH-benzimidazole hydrochloride and its conversion to omeprazole

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4620008A (en) * 1982-08-26 1986-10-28 Aktiebolaget Hassle Processes for the preparation of omeprazole and intermediates therefore
CN1042705A (en) * 1988-11-15 1990-06-06 Cl药物股份公司 3,5-dimethyl-4-methoxypyridine derivatization method and be used for the novel intermediate product of this method for making
CN1098405A (en) * 1993-07-02 1995-02-08 拜尔公司 The method for preparing chloromethyl pyridine compound
CN1135481A (en) * 1994-12-23 1996-11-13 拜尔公司 Preparation method for chloromethyl pyridine compound
US6245913B1 (en) * 1999-06-30 2001-06-12 Wockhardt Europe Limited Synthetic procedure for 5-methoxy-2-[(4-methoxy-3,5-dimethyl-2-pyridinyl)-methylthio]-IH-benzimidazole hydrochloride and its conversion to omeprazole

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
《化学世界》 20000425 谭国洪,等 2-氯-5-氯甲基吡啶及吡虫啉的合成 第206-207页 3-4 第41卷, 第04期 *
付涛,等: "2-氯-5-氯甲基吡啶的合成", 《河北化工》, vol. 31, no. 09, 20 September 2008 (2008-09-20), pages 20 - 21 *
冯晓亮,等: "2-氯-5-氯甲基吡啶的合成方法及其在农药合成中的应用", 《浙江化工》, vol. 32, no. 02, 30 July 2001 (2001-07-30), pages 50 - 51 *
刘秀兰: "奥咪拉唑的合成", 《山西医科大学学报》, vol. 33, no. 04, 30 August 2002 (2002-08-30), pages 331 - 3 *
谭国洪,等: "2-氯-5-氯甲基吡啶及吡虫啉的合成", 《化学世界》, vol. 41, no. 04, 25 April 2000 (2000-04-25), pages 206 - 207 *

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103880741A (en) * 2014-02-28 2014-06-25 安徽国星生物化学有限公司 Preparation method of 2-chloromethyl-3,5-dimethyl-4-alkoxypyridyl-N-oxide
CN104974078A (en) * 2015-06-25 2015-10-14 黄荣辉 Preparation method of 2-methyl-6-chloromethylpyridinehydrochloride
CN105198799A (en) * 2015-11-03 2015-12-30 江苏梦得电镀化学品有限公司 Preparation method of 2-methyl-6-(chloromethyl) pyridine hydrochloride
CN111638303A (en) * 2020-06-08 2020-09-08 安徽大学 Distinguish metal ion Al3+And Zn2+Method (2)
CN111638303B (en) * 2020-06-08 2022-06-24 安徽大学 Distinguish metal ion Al3+And Zn2+Method (2)

Also Published As

Publication number Publication date
CN102603620B (en) 2014-10-29

Similar Documents

Publication Publication Date Title
CN102603620B (en) Synthetic method of chloromethylpyridine or pyridine derivative hydrochloride of chloromethylpyridine
CN103641840A (en) Method for synthesizing and purifying 5-isosorbide mononitrate
CN103880596A (en) Preparation method of butoconazole nitrate intermediate suitable for industrial production
CN102167405B (en) New method for preparing ruthenium nitrosylnitrate solid
CN106674084B (en) A kind of preparation method of 2- isopropyl oxygroup -5- methyl -4- (piperidin-4-yl) aniline dihydrochloride
CN106008183B (en) Preparation method of ephedrine or pseudoephedrine and ephedrine or pseudoephedrine intermediate
CN105566405B (en) The preparation method of high-purity Topiramate
CN102399223B (en) Preparation method of medicinal calcium folinate
CN105646446A (en) An alogliptin purifying method
CN104326512A (en) Nickel fluoride preparation method
CN112441966A (en) Method for producing 2-chloro-3-trifluoromethylpyridine from 2,3, 6-trichloro-5-trifluoromethylpyridine
CN101486680B (en) Method for industrial production of miconazole nitrate
CN103664750A (en) Synthetic method of prazole chloride
CN103421004A (en) 5-azaindole preparation method
CN101817779A (en) Novel synthesis process of N-benzyl-3-piperidinol, novel nickel-based catalyst and preparation method thereof
CN104693144B (en) A kind of N-(2-chloroethyl) synthetic method of hexamethylene imine hydrochlorate
CN104974078A (en) Preparation method of 2-methyl-6-chloromethylpyridinehydrochloride
CN102603594A (en) Preparation method of (S)-oxiracetam
CN102459243A (en) Process for preparing olmesartan medoxomil
CN109438356B (en) Method for purifying prochloraz technical
CN102603595A (en) Preparation method of (S)-oxiracetam
CN102030705B (en) Synthesis method of 7- benzyloxy-6-methoxyl-4-hydroxyquinoline
CN105418507A (en) Preparation method for 1-(3-methyl-1-phenyl-1H-pyrazole-5-yl)piperazine
CN105085377A (en) Synthetic method of 3-(chloromethyl)pyridine hydrochloride
CN105198799A (en) Preparation method of 2-methyl-6-(chloromethyl) pyridine hydrochloride

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
EE01 Entry into force of recordation of patent licensing contract
EE01 Entry into force of recordation of patent licensing contract

Application publication date: 20120725

Assignee: Nanjing Red Sun Pharmaceutical Research Institute Co.,Ltd.

Assignor: Jiangsu Zhongbang Pharmaceutical Co.,Ltd.

Contract record no.: X2022980010825

Denomination of invention: A synthetic method of chloromethyl pyridine or its pyridine derivative hydrochloride

Granted publication date: 20141029

License type: Common License

Record date: 20220721